Zinc finger protein 334 (ZNF334) is a protein encoded by the ZNF334 gene, belonging to the Krüppel-like family of zinc finger proteins. Zinc finger proteins are characterized by their finger-like protrusions, each stabilized by a zinc ion and commonly involving the coordination of cysteine and histidine residues. The zinc finger domains facilitate specific interactions with DNA, allowing these proteins to act as transcription factors that regulate gene expression.ZNF334, like other members of its family, is presumed to participate in transcriptional regulation by binding to DNA through its zinc finger motifs. This binding typically occurs at gene promoter regions, where ZNF334 can either activate or repress the transcription of downstream genes. The precise DNA-binding specificity of ZNF334 is determined by the amino acid sequence within its finger domains, which dictates its interaction with particular DNA sequences.
Although ZNF334 is part of a well-defined family of proteins, the specifics of its function and the identity of its target genes are not as thoroughly characterized as those of some other zinc finger proteins. Its role in cellular processes such as cell proliferation, differentiation, and apoptosis may be inferred based on the functions of closely related zinc finger proteins, but direct evidence for these activities remains to be established.Understanding the role of ZNF334 in gene expression is crucial, as transcription factors are key regulators of cell fate and function. Misregulation of proteins like ZNF334 can lead to aberrant gene expression patterns, contributing to the development of various diseases, including cancers and genetic disorders. Research into ZNF334 may uncover novel insights into transcriptional regulation and offer potential targets for intervention in diseases where ZNF334 activity is dysregulated.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which may activate PKA. PKA could then phosphorylate transcription factors or coactivators associated with ZNF334, enhancing its activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor that alters chromatin structure, potentially increasing accessibility of the ZNF334 gene for transcription and thereby enhancing protein activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that could lead to demethylation of the ZNF334 gene promoter, enhancing transcription and upregulating protein activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate gene expression through retinoic acid receptors, which may interact with the ZNF334 gene promoter to enhance its transcription. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which may influence the phosphorylation state of proteins that regulate ZNF334 activity, leading to its functional enhancement. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to affect various signaling pathways that could potentially enhance the activity of transcription factors, including those affecting ZNF334. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which might shift cellular signaling in a way that indirectly activates ZNF334 through altered transcription factor dynamics. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that could have a similar effect to LY294002, potentially enhancing ZNF334 activity by modifying transcription factor activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which could lead to a reconfiguration of cellular signaling networks, indirectly affecting ZNF334 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, potentially leading to changes in transcription factor activity and enhancing ZNF334 function. | ||||||